NEW YORK (GenomeWeb) – Fluidigm, Sequenom, and Foundation Medicine each saw big drops in their share prices month over month in May, while, overall, stocks in the omics tools and molecular diagnostics spaces improved about 3 percent. 

For May, 21 of the 31 firms in the GenomeWeb Index saw gains in their share prices, paced by Exact Sciences, whose stock rose 29 percent month over month. Meanwhile, NanoString Technologies' stock increased almost 18 percent, while Illumina's stock was up about 12 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.